NEWS CENTER

Together, let's paint a new blueprint for growth! Keyuan Pharmaceutical & Linuo Pharmaceutical Shine at the 18th Growth-oriented Pharmaceutical Enterprise Development Conference!

Publish Time:

2024-11-26

Recently, the highly anticipated 18th Growth-oriented Pharmaceutical Enterprise Development Conference was grandly held at the Xiamen Bixiang Convention and Exhibition Center. With the theme "Growth Power—Shared Challenges and Responsibilities," the conference brought together leading enterprises, expert scholars, and prominent investment institutions from China's pharmaceutical industry. Grounded in responsibility and fueled by challenges, participants jointly explored future pathways for the pharmaceutical sector.

Recently, the highly anticipated 18th Growth-oriented Pharmaceutical Enterprise Development Conference was grandly held at the Xiamen Bixiang Convention and Exhibition Center. With the theme "Growth Power – Shared Challenges and Responsibilities," the conference brought together leading enterprises, renowned experts and scholars, as well as elite representatives from investment institutions across China's pharmaceutical industry. Grounded in responsibility and fueled by challenges, participants jointly explored future pathways for the pharmaceutical sector.

Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical showcased at this year's conference and jointly received multiple prestigious awards from the event.

On the journey of exploring pharmaceutical companies' growth potential, "shared challenges and responsibilities" has emerged as a keyword we cannot afford to overlook. Faced with a rapidly evolving market environment, increasingly stringent regulatory demands, and ever-rising consumer expectations, pharmaceutical companies must join forces to tackle multifaceted challenges—including product quality, technological innovation, and social responsibility—head-on.

Facing the challenges and responsibilities of growth, Keyuan Pharmaceutical & Linuo Pharmaceutical have demonstrated outstanding dedication and commitment. Driven primarily by technological R&D, intelligent manufacturing, and cultural marketing, the companies have invested significant resources to propel product upgrades. They have established a provincial-level enterprise technology center and the Jinan municipal postdoctoral innovation practice base, while also forging long-term, stable partnerships with numerous research institutions and universities. Together, these collaborations focus on advancing scientific and technological projects, accelerating the commercialization of research outcomes, and nurturing top-tier talent, ultimately enabling the companies to achieve steady and sustainable growth.

The company is actively building a state-of-the-art, digitally and information-integrated smart manufacturing facility designed with the latest technologies, creating a secure, green, low-carbon, and eco-friendly smart industrial park. This initiative makes a positive contribution to sustainable development and demonstrates the company’s commitment to corporate social responsibility through concrete actions.

Huang Shuai, Vice President of Retail at Linuo Pharmaceutical

At the conference venue, Keyuan Pharmaceutical and Linuo Pharmaceutical engaged in in-depth discussions with attending guests and actively participated in various thematic activities, including "Capital Empowering Industry Restructuring and Revitalization" and the "Primary Healthcare Development Conference," thoroughly analyzing the latest trends in the pharmaceutical industry while sharing their successful experiences.

Mr. Jiang Hongsheng, Chairman and President of Keyuan Pharmaceutical, served as the moderator for this Capital Forum, guiding attendees in an in-depth discussion on new models that integrate capital with industry, while offering valuable insights and recommendations to help pharmaceutical and healthcare companies achieve transformative growth and upgrades.

At this year's conference, Keyuan Pharmaceutical and Linuo Pharmaceutical received multiple honors. Thanks to their outstanding performance in brand building, market expansion, and quality assurance, Linuo Pharmaceutical was awarded the prestigious "Annual Excellence Brand Award." Meanwhile, Mr. Jiang Hongsheng was honored with the "Annual Influential Entrepreneur" award at the conference, recognizing his remarkable contributions and significant impact on the industry.

Honors are not only a high recognition of our strength but also an effective incentive for future development. Keyuan Pharmaceutical and Linuo Pharmaceutical will embrace a more open mindset, innovative thinking, and pragmatic actions as we proactively tackle the challenges and seize the opportunities ahead. Together with our partners across the industry chain—both upstream and downstream—we will jointly enhance the core competitiveness of our sector, continuously fostering innovation and intrinsic momentum within the broader pharmaceutical and healthcare industry. In doing so, we aim to further contribute to the creation of a digital and intelligent health ecosystem, delivering comprehensive support for China’s Healthy China initiative and making new, even greater strides toward this vital goal.

Strengthen the security "firewall"! Keyuan Pharmaceutical Holds Fire Emergency Drill Activity!

Promoting learning through competition and strengthening foundations with "quality" | Keyuan Pharmaceutical Successfully Hosts QC Laboratory Operation Skills Competition!

Strengthen the security "firewall"! Keyuan Pharmaceutical Holds Fire Emergency Drill Activity!

Promoting learning through competition and strengthening foundations with "quality" | Keyuan Pharmaceutical Successfully Hosts QC Laboratory Operation Skills Competition!